Papatheodoridi, M;
Mazza, G;
Pinzani, M;
(2020)
Regenerative hepatology: In the quest for a modern prometheus?
Digestive and Liver Disease
, 52
(10)
pp. 1106-1114.
10.1016/j.dld.2020.08.001.
Preview |
Text
Pinzani_Dig Liver Dis Reg Hep Review revised 23072020.pdf - Accepted Version Download (389kB) | Preview |
Abstract
As liver-related morbidity and mortality is rising worldwide and orthotopic liver transplantation (OLT) remains the only standard-of-care for end-stage liver disease or acute liver failure, shortage of donor organs is becoming more prominent. Importantly, advances in regenerative Hepatology and liver bioengineering are bringing new hope to the possibility of restoring impaired hepatic functionality in the presence of acute or chronic liver failure. Hepatocyte transplantation and artificial liver-support systems were the first strategies used in regenerative hepatology but have presented various types of efficiency limitations restricting their widespread use. In parallel, liver bioengineering has been a rapidly developing field bringing continuously novel advancements in biomaterials, three dimensional (3D) scaffolds, cell sources and relative methodologies for creating bioengineered liver tissue. The current major task in liver bioengineering is to build small implantable liver mass for treating inherited metabolic disorders, bioengineered bile ducts for congenital biliary defects and large bioengineered liver organs for transplantation, as substitutes to donor-organs, in cases of acute or acute-on-chronic liver failure. This review aims to summarize the state-of-the-art and upcoming technologies of regenerative Hepatology that are emerging as promising alternatives to the current standard-of care in liver disease.
Loading...
Loading...Loading...Loading...Archive Staff Only
 |
View Item |
